Evidence map›Paper›PMID 38721639›Full record

ArticleDiabetic medicine : a journal of the British Diabetic Association2024

The diabetes body project: Study protocol of a multi-site trial of a virtually delivered eating disorder prevention program for young women with type 1 diabetes.

Severina Haugvik, Mareille Hennekes, Eric Stice, Maartje de Wit, Elena Toschi, Line Wisting

Registry-linked trialAbstract readClinical Trial Protocol
PubMed Full text at PMC Publisher
In one paragraph

Article in Diabetic medicine : a journal of the British Diabetic Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05399446 (Multi-site Trial of a Virtually Delivered Eating Disorder Prevention Program for Young People with Type 1 Diabetes), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05399446 naactive not recruitingnot on this map

Multi-site Trial of a Virtually Delivered Eating Disorder Prevention Program for Young People with Type 1 Diabetes

TypeinterventionalSponsorOslo University HospitalRan2023 to 2027Enrolled280ConditionsType 1 Diabetes, Eating DisordersArmsDiabetes Body Project, Educational Group
3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Severina HaugvikOslo University Hospital, Oslo, Norway.
Mareille HennekesAmsterdam UMC, Location Vrije Universiteit Amsterdam, Medical Psychology, de Boelelaan 1117, Amsterdam, Netherlands.
Eric SticeDepartment of Psychiatry and Behavioral Sciences, Stanford University, Stanford, California, USA.
Maartje de WitAmsterdam UMC, Location Vrije Universiteit Amsterdam, Medical Psychology, de Boelelaan 1117, Amsterdam, Netherlands.ORCID https://orcid.org/0000-0001-6029-5101
Elena ToschiJoslin Diabetes Center, Harvard Medical School, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0003-4077-1160
Line WistingOslo University Hospital, Oslo, Norway.

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI ROHIT N. KULKARNI · 1986 to 2026
$50.5M
NIDDK NIH HHS P30 DK036836
6 · The paper itself

Abstract

aimYoung women with type 1 diabetes are a high-risk population for eating disorders (ED). Prevention programs are lacking. In young women without diabetes, the Body Project has produced reductions in ED risk factors, ED symptoms and future ED onset. Therefore, the Body Project was adapted to type 1 diabetes, the Diabetes Body Project (DBP). In this protocol, we describe the multi-site randomized controlled trial (RCT) to evaluate efficacy of the DBP.

methodsThis is an ongoing RCT with four sites (Europe and US). In total 280, 14-35 year-old, women with type 1 diabetes ≥1 year and some level of body image concerns will be recruited in 2023. Participants are randomized to either virtual DBP groups or an educational control. The study constitutes 5 measurement points distributed over 2 years. The primary aim is to test if DBP will produce significantly greater reductions in ED behaviours, ED symptoms and future ED onset. The secondary aim is to test if DBP has significantly greater improvements in diabetes distress, quality of life and glycaemic outcomes.

resultsWe expect that DBP will be more efficacious in reducing ED behaviours, ED symptoms and ED onset compared to the control condition. Additionally, we hope to gain new knowledge on how DBP may affect diabetes-related outcomes.

conclusionsIf DBP proves efficacious, it has potential for immediate, clinical implementation at low-cost and may contribute to broad prevention of future ED onset among young women with type 1 diabetes. CLINICALTRIALS: GOV IDENTIFIER: NCT05399446.

Indexed as

Diabetes Mellitus, Type 1Feeding and Eating DisordersAdolescentAdultBody ImageFemaleHumansMulticenter Studies as TopicQuality of LifeRandomized Controlled Trials as TopicYoung Adulteating disorderpreventionstudy protocoltype 1 diabetesvirtual

Identifiers

PMID38721639
PMCPMC12704150

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.